Literature DB >> 28074069

Myelodysplastic syndromes and bone loss in mice and men.

H Weidner1, M Rauner2,3, F Trautmann4,5, J Schmitt4,5, E Balaian1, A Mies1, S Helas1, U Baschant2,3, C Khandanpour6, M Bornhäuser1,7, L C Hofbauer2,3,7, U Platzbecker1,7.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28074069     DOI： 10.1038/leu.2017.7

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Anemia as a risk factor for low bone mineral density in postmenopausal Turkish women.

Authors:  Ugur Korkmaz; Nurdan Korkmaz; Selma Yazici; Melih Erkan; Ali Erdem Baki; Mehmet Yazici; Hakan Ozhan; Safinaz Ataoğlu
Journal:  Eur J Intern Med       Date:  2011-12-09       Impact factor: 4.487

2.  Thalassemia bone disease: a 19-year longitudinal analysis.

Authors:  Phillip Wong; Peter J Fuller; Matthew T Gillespie; Vicky Kartsogiannis; Peter G Kerr; James Cg Doery; Eldho Paul; Donald K Bowden; Boyd J Strauss; Frances Milat
Journal:  J Bone Miner Res       Date:  2014-11       Impact factor: 6.741

3.  Anemia is associated with bone mineral density in chronic obstructive pulmonary disease.

Authors:  Erica P A Rutten; Frits M E Franssen; Martijn A Spruit; Emiel F M Wouters
Journal:  COPD       Date:  2012-12-28       Impact factor: 2.409

4.  Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells.

Authors:  S Geyh; S Oz; R-P Cadeddu; J Fröbel; B Brückner; A Kündgen; R Fenk; I Bruns; C Zilkens; D Hermsen; N Gattermann; G Kobbe; U Germing; F Lyko; R Haas; T Schroeder
Journal:  Leukemia       Date:  2013-03-29       Impact factor: 11.528

5.  Bone mineral density in children with fanconi anemia after hematopoietic cell transplantation.

Authors:  Anna Petryk; Lynda E Polgreen; Jessie L Barnum; Lei Zhang; James S Hodges; K Scott Baker; John E Wagner; Julia Steinberger; Margaret L MacMillan
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-13       Impact factor: 5.742

6.  Burden of soft-tissue and bone sarcoma in routine care: Estimation of incidence, prevalence and survival for health services research.

Authors:  Freya Trautmann; Markus Schuler; Jochen Schmitt
Journal:  Cancer Epidemiol       Date:  2015-03-21       Impact factor: 2.984

7.  NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia.

Authors:  Ying-Wei Lin; Christopher Slape; Zhenhua Zhang; Peter D Aplan
Journal:  Blood       Date:  2005-03-08       Impact factor: 22.113

8.  Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit.

Authors:  Hind Medyouf; Maximilian Mossner; Johann-Christoph Jann; Florian Nolte; Simon Raffel; Carl Herrmann; Amelie Lier; Christian Eisen; Verena Nowak; Bettina Zens; Katja Müdder; Corinna Klein; Julia Obländer; Stephanie Fey; Jovita Vogler; Alice Fabarius; Eva Riedl; Henning Roehl; Alexander Kohlmann; Marita Staller; Claudia Haferlach; Nadine Müller; Thilo John; Uwe Platzbecker; Georgia Metzgeroth; Wolf-Karsten Hofmann; Andreas Trumpp; Daniel Nowak
Journal:  Cell Stem Cell       Date:  2014-04-03       Impact factor: 24.633

9.  Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes.

Authors:  Jochen Schmitt; Kristin Schwarz; Hansjörg Baurecht; Melanie Hotze; Regina Fölster-Holst; Elke Rodríguez; Young A E Lee; Andre Franke; Frauke Degenhardt; Wolfgang Lieb; Christian Gieger; Michael Kabesch; Markus M Nöthen; Alan D Irvine; W H Irwin McLean; Stefanie Deckert; Victoria Stephan; Peter Schwarz; Martin Aringer; Natalija Novak; Stephan Weidinger
Journal:  J Allergy Clin Immunol       Date:  2015-08-04       Impact factor: 10.793

Review 10.  Myelodysplasia is in the niche: novel concepts and emerging therapies.

Authors:  E Bulycheva; M Rauner; H Medyouf; I Theurl; M Bornhäuser; L C Hofbauer; U Platzbecker
Journal:  Leukemia       Date:  2014-11-14       Impact factor: 11.528
View more
  9 in total

Review 1.  The microenvironment in myelodysplastic syndromes: Niche-mediated disease initiation and progression.

Authors:  Allison J Li; Laura M Calvi
Journal:  Exp Hematol       Date:  2017-08-18       Impact factor: 3.084

Review 2.  Interconnections of fibroblast growth factor 23 and klotho with erythropoietin and hypoxia-inducible factor.

Authors:  Baris Afsar; Mehmet Kanbay; Rengin Elsurer Afsar
Journal:  Mol Cell Biochem       Date:  2022-04-05       Impact factor: 3.396

3.  Machine Learning of Bone Marrow Histopathology Identifies Genetic and Clinical Determinants in Patients with MDS.

Authors:  Oscar E Brück; Susanna E Lallukka-Brück; Helena R Hohtari; Aleksandr Ianevski; Freja T Ebeling; Panu E Kovanen; Soili I Kytölä; Tero A Aittokallio; Pedro M Ramos; Kimmo V Porkka; Satu M Mustjoki
Journal:  Blood Cancer Discov       Date:  2021-03-22

4.  The Coming of Age of Preclinical Models of MDS.

Authors:  Wei Liu; Patric Teodorescu; Stephanie Halene; Gabriel Ghiaur
Journal:  Front Oncol       Date:  2022-03-16       Impact factor: 5.738

5.  Increased FGF-23 levels are linked to ineffective erythropoiesis and impaired bone mineralization in myelodysplastic syndromes.

Authors:  Heike Weidner; Ulrike Baschant; Franziska Lademann; Maria G Ledesma Colunga; Ekaterina Balaian; Christine Hofbauer; Barbara M Misof; Paul Roschger; Stéphane Blouin; William G Richards; Uwe Platzbecker; Lorenz C Hofbauer; Martina Rauner
Journal:  JCI Insight       Date:  2020-08-06

Review 6.  Senescent Mesenchymal Stem Cells in Myelodysplastic Syndrome: Functional Alterations, Molecular Mechanisms, and Therapeutic Strategies.

Authors:  Xiaofang Chen; Ningyu Li; Jianyu Weng; Xin Du
Journal:  Front Cell Dev Biol       Date:  2021-02-11

7.  Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia.

Authors:  Lachelle D Weeks; Catherine R Marinac; Robert Redd; Gregory Abel; Amy Lin; Mridul Agrawal; Richard M Stone; Deborah Schrag; Benjamin L Ebert
Journal:  Blood       Date:  2022-02-24       Impact factor: 25.476

8.  Aberrant Bone Homeostasis in AML Is Associated with Activated Oncogenic FLT3-Dependent Cytokine Networks.

Authors:  Isabel Bär; Volker Ast; Daria Meyer; Rainer König; Martina Rauner; Lorenz C Hofbauer; Jörg P Müller
Journal:  Cells       Date:  2020-11-09       Impact factor: 6.600

9.  Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathway.

Authors:  Ekaterina Balaian; Manja Wobus; Heike Weidner; Ulrike Baschant; Maik Stiehler; Gerhard Ehninger; Martin Bornhäuser; Lorenz C Hofbauer; Martina Rauner; Uwe Platzbecker
Journal:  Haematologica       Date:  2017-10-27       Impact factor: 9.941
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.